Key Data in Non-Hodgkin Lymphoma From ASH 2022 Key Data in Non-Hodgkin Lymphoma From ASH 2022

The best consolidation therapy in CNS lymphoma, bispecific antibodies, and rituximab vs watch and wait are among top picks in non-Hodgkin lymphoma from ASH 2022, reported by Dr Michael Bishop.Medscape

Source: Medscape Today Headlines - January 3, 2023 Category: Consumer Health News Tags: Hematology-Oncology ReCAP Source Type: news